| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/bmcsb/PiruzianBIAMMNN10 |
| P6179 | Dimensions Publication ID | 1018771226 |
| P356 | DOI | 10.1186/1752-0509-4-41 |
| P3181 | OpenCitations bibliographic resource ID | 2916483 |
| P932 | PMC publication ID | 2873316 |
| P698 | PubMed publication ID | 20377895 |
| P5875 | ResearchGate publication ID | 47248201 |
| P2093 | author name string | Yuri Nikolsky | |
| Alex Ishkin | |||
| Eleonora Piruzian | |||
| Rustam Abdeev | |||
| Sergey Bruskin | |||
| Sergey Moshkovskii | |||
| Stanislav Melnik | |||
| Tatiana Nikolskaya | |||
| P2860 | cites work | Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin | Q24320188 |
| Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes | Q24811346 | ||
| Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein | Q28215634 | ||
| Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin | Q28301222 | ||
| Network-based classification of breast cancer metastasis | Q29616384 | ||
| Integrated analysis of DNA copy number and gene expression microarray data using gene sets | Q30490621 | ||
| Statistical issues and methods for meta-analysis of microarray data: a case study in prostate cancer | Q30814452 | ||
| Overexpression of serpin squamous cell carcinoma antigens in psoriatic skin | Q30814682 | ||
| Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis | Q30829061 | ||
| Integrated transcriptome and proteome data: the challenges ahead | Q30980118 | ||
| Integrating gene and protein expression data: pattern analysis and profile mining | Q30983191 | ||
| Biological networks and analysis of experimental data in drug discovery | Q30989837 | ||
| New data analysis and mining approaches identify unique proteome and transcriptome markers of susceptibility to autoimmune diabetes | Q31011604 | ||
| Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. | Q33219961 | ||
| Type I interferon: potential therapeutic target for psoriasis? | Q33354097 | ||
| RankAggreg, an R package for weighted rank aggregation | Q33410683 | ||
| Identifying disease-specific genes based on their topological significance in protein networks | Q33421110 | ||
| Comparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers | Q33428572 | ||
| Estimating accuracy of RNA-Seq and microarrays with proteomics | Q33431012 | ||
| Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. | Q52018451 | ||
| E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. | Q52058501 | ||
| Increased expression of Wnt5a in psoriatic plaques. | Q52931634 | ||
| Identification of novel functional differences in monocyte subsets using proteomic and transcriptomic methods. | Q53390188 | ||
| Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor gammadelta in plaque and guttate psoriasis. | Q53557801 | ||
| Proteomic and transcriptomic analyses of macrophages with an increased resistance to oxidized low density lipoprotein (oxLDL)-induced cytotoxicity generated by chronic exposure to oxLDL. | Q53851433 | ||
| Expression and divalent cation binding properties of the novel chemotactic inflammatory protein psoriasin. | Q54577651 | ||
| Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity. | Q54674355 | ||
| Expression of integrin subunits and CD44 isoforms in psoriatic skin and effects of topical calcitriol application | Q56087794 | ||
| Pulling the trigger on psoriasis | Q59041460 | ||
| Tissue specificity of E- and P-selectin ligands in Th1-mediated chronic inflammation | Q60673541 | ||
| Blockade of CD11a by Efalizumab in Psoriasis Patients Induces a Unique State of T-Cell Hyporesponsiveness | Q60683093 | ||
| Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies | Q61647750 | ||
| Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro | Q62662014 | ||
| Quantitative Proteomic and Genomic Profiling Reveals Metastasis-Related Protein Expression Patterns in Gastric Cancer Cells | Q63641884 | ||
| Exacerbation of psoriasis with GM-CSF therapy | Q70719232 | ||
| Expression of the T-cell activation antigens CD27 and CD28 in normal and psoriatic skin | Q71401739 | ||
| Adhesion molecules and IL-1 costimulate T lymphocytes in the autologous MECLR in psoriasis | Q71809981 | ||
| Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis | Q73587996 | ||
| Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris | Q73778362 | ||
| Expression and function of beta 2 integrin CD11B/CD18 on leukocytes from patients with psoriasis | Q77401167 | ||
| Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling | Q77813238 | ||
| Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis | Q79252702 | ||
| Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis | Q80570288 | ||
| [The comparative analysis of psoriasis and Crohn disease molecular-genetical processes under pathological conditions] | Q83587563 | ||
| The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma | Q33436471 | ||
| Network analysis of human glaucomatous optic nerve head astrocytes. | Q33442021 | ||
| Functional analysis of OMICs data and small molecule compounds in an integrated "knowledge-based" platform | Q33481685 | ||
| Network analysis of genes regulated in renal diseases: implications for a molecular-based classification | Q33504378 | ||
| Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia | Q33836409 | ||
| Identification of coexpressed gene clusters in a comparative analysis of transcriptome and proteome in mouse tissues. | Q33842906 | ||
| c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny | Q33947752 | ||
| Keratins (Kl6 and Kl7) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro | Q34296920 | ||
| Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance | Q34314752 | ||
| Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. | Q34509419 | ||
| A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses | Q35184175 | ||
| c-Myc promotes differentiation of human epidermal stem cells | Q35194892 | ||
| Interleukin 4 treatment of psoriasis: are pleiotropic cytokines suitable therapies for autoimmune diseases? | Q35599831 | ||
| Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor | Q35945026 | ||
| BX471: a CCR1 antagonist with anti-inflammatory activity in man. | Q36264519 | ||
| Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases | Q36865332 | ||
| Differential expression of syndecans and glypicans in chronically inflamed synovium | Q36927550 | ||
| Biologic therapies in psoriasis: a new therapeutic approach | Q36940159 | ||
| Genes and structure of selected cytokines involved in pathogenesis of psoriasis. | Q37093175 | ||
| Protein networks in disease | Q37125547 | ||
| Biological drugs targeting the immune response in the therapy of psoriasis | Q37307801 | ||
| S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway | Q37331858 | ||
| NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis | Q37370811 | ||
| The HLA genomic loci map: expression, interaction, diversity and disease | Q37374223 | ||
| IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach | Q37378185 | ||
| Soluble forms of RAGE in human diseases: clinical and therapeutical implications | Q37411352 | ||
| Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics | Q38302527 | ||
| Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array | Q38356616 | ||
| Genome-wide functional synergy between amplified and mutated genes in human breast cancer | Q39916347 | ||
| Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients | Q40211593 | ||
| Aetiology and pathogenesis of psoriasis | Q41350692 | ||
| The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis | Q42435508 | ||
| Innate immune-related receptors in normal and psoriatic skin | Q42436530 | ||
| The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis | Q42473294 | ||
| Meta-analysis of genome searches | Q42622749 | ||
| A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. | Q45963740 | ||
| The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha | Q46865500 | ||
| Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late | Q47588197 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | applied mathematics | Q33521 |
| transcriptome | Q252857 | ||
| structural biology | Q908902 | ||
| P304 | page(s) | 41 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | BMC Systems Biology | Q4835949 |
| P1476 | title | Integrated network analysis of transcriptomic and proteomic data in psoriasis | |
| P478 | volume | 4 |
| Q26781378 | Biomarkers of An Autoimmune Skin Disease--Psoriasis |
| Q38474670 | Comparisons of gene expression in normal, lesional, and non-lesional psoriatic skin using DNA microarray techniques |
| Q92460729 | Comprehensive Proteomic Analysis Reveals Intermediate Stage of Non-Lesional Psoriatic Skin and Points out the Importance of Proteins Outside this Trend |
| Q28255491 | Cytokines in psoriasis |
| Q36045304 | Eph/ephrin signaling in epidermal differentiation and disease |
| Q36321202 | Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis |
| Q35659961 | Gender-specific cytokine pathways, targets, and biomarkers for the switch from health to adenoma and colorectal cancer. |
| Q30359391 | Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets. |
| Q30665898 | Integrated analysis of global mRNA and protein expression data in HEK293 cells overexpressing PRL-1. |
| Q38876517 | Integrating transcriptome and proteome profiling: Strategies and applications |
| Q33987965 | Integrative network biology: graph prototyping for co-expression cancer networks |
| Q30836930 | Integrative omics analysis. A study based on Plasmodium falciparum mRNA and protein data |
| Q42730640 | Interorgan coordination of the murine adaptive response to fasting |
| Q43470841 | Mapping the protein profile involved in the biotransformation of organoarsenicals using an arsenic metabolizing bacterium |
| Q48132042 | Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis. |
| Q37325837 | Moving H5N1 studies into the era of systems biology |
| Q37258222 | Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis |
| Q29248636 | Prediction of chemo-response in serous ovarian cancer |
| Q38200069 | Proteases and proteomics: cutting to the core of human skin pathologies |
| Q38230695 | Proteomics focusing on immune markers in psoriatic arthritis. |
| Q34884113 | Proteomics of skin proteins in psoriasis: from discovery and verification in a mouse model to confirmation in humans |
| Q58235909 | Psoriasis |
| Q37673703 | Study on Certain Biomarkers of Inflammation in Psoriasis Through "OMICS" Platforms |
| Q38615784 | The role of Eph receptors and Ephrins in the skin |
Search more.